Featured
Last news
Prayer and dance: hundreds of millions in Asia celebrate Year of the Snake
From incense offerings and vibrant lion dances in Beijing to prayer rituals at temples in Bangkok and Taipei, hundreds of millions of people across Asia celebrated the Lunar New Year on Wednesday, ushering in the Year of the Snake.
15 dead in India stampede at Hindu mega-festival
A stampede at the world's largest religious gathering in India killed at least 15 people with many more injured, a doctor at the Kumbh Mela festival told AFP Wednesday.
15 dead in India after stampede at Hindu mega-festival
A stampede at the world's largest religious gathering in India killed at least 15 people with many more injured, a doctor at the Kumbh Mela festival in Prayagraj told AFP Wednesday.
The International Surface Event Honors Over 15 Standout Products at the Inaugural "What's Hot - Best of tise" 2025 Awards
Winning brands include industry leaders MOHAWK, Mannington, Engineer Floors and Biesse GMM, among others.
Menorah Life - Notice of Data Security Incident
ST. PETERSBURG, FLORIDA / ACCESS Newswire / January 29, 2025 / Menorah Life is committed to protecting the privacy and security of its patients' health information. We are writing regarding a data security incident that may have affected the protected health information of certain Menorah Life patients.
Protagonist to Host Investor Event with KOL Insights on Polycythemia Vera (PV) and the Hepcidin Mimetic Rusfertide in New York on February 6, 2025
NEWARK, CALIFORNIA / ACCESS Newswire / January 29, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company")will host an in-person and virtual investor event on Thursday, February 6, 2025, at 10:30 AM ET in New York. To register, click here.
Onco-Innovations' Private Placement Fully Subscribed
Not for distribution to United States wire services or for dissemination in the United States
Pharma-Bio Serv Announces Full Year Results
DORADO, PUERTO RICO / ACCESS Newswire / January 29, 2025 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries, today announced that revenues for the year ended October 31, 2024 were approximately $9.5 million, a decrease of approximately $7.5 million when compared to last year. Additionally, a net loss for the year ended October 31, 2024 was reported of approximately $0.8 million, compared to a net income of approximately $1.3 million for last year.
Pharma-Bio Serv Announces Special Dividend
DORADO, PUERTO RICO / ACCESS Newswire / January 29, 2025 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries, today announced that the Board of Directors approved a Special Dividend of $0.075 per share for shareholders. The Special Dividend will be payable on or about March 20, 2025 to shareholders of record at the close of business on February 28, 2025.
Dermata to Present on BioPub on January 31, 2025
- Dermata's Chief Executive Officer and Chief Development Officer will provide a corporate update and answer live questions from the biotech investment community -
Day & Night Air Conditioning, Heating and Plumbing Launches "Oldest A/C Contest" to Help Homeowners Beat the Heat With a Brand-New System
Phoenix Homeowners Invited to Enter to Win a Energy-efficient Air Conditioning System
Aviva Aesthetics Partners with Renew MedSpa, Expanding Footprint to the Midwest
CHICAGO, IL & EAGAN, MN / ACCESS Newswire / January 29, 2025 / Aviva Aesthetics, the only entrepreneur-owned and led medical aesthetics platform, is excited to announce its partnership with Renew MedSpa, a leading medical spa based in Eagan, Minnesota.
Ambience Healthcare Joins athenahealth's Marketplace Program to Support Clinicians with AI-assisted Documentation, Point of Care CDI & Coding, and Care Coordination
SAN FRANCISCO, CA / ACCESS Newswire / January 29, 2025 / Ambience Healthcare, the leading enterprise AI platform for documentation, CDI & coding, and care coordination, today announced an agreement with athenahealth, Inc through the company's Marketplace program. As part of the athenahealth® Marketplace, Ambience's AI technology, which recently received a 97.7% Spotlight Report score from KLAS Research in the Ambient AI category*, is now available to athenahealth's growing network of healthcare providers.
Jaguar Health Supports Evaluation of FDA-Approved Crofelemer to Address GI Side Effects of GLP-1 and Other Weight Loss Therapies: Files Patent Application with USPTO
Gastrointestinal disorders are the most frequently reported adverse effects during clinical trials of GLP-1 agonists; GI adverse events usually develop in 40-70% of treated patients, and have been reported in up to 85%Crofelemer, approved by the FDA under the brand name Mytesi® for HIV-related diarrhea, has demonstrated a significant benefit in improving gastrointestinal symptoms, including diarrhea, abdominal pain and discomfort, incontinence, bloating and constipation, when studied in populations with HIV-related diarrhea, cancer therapy-related diarrhea, and IBSCrofelemer could have a significant supportive impact on GLP-1 therapies, one of the fastest growing classes of drugs, estimated to be a $56 billion global market in 2025 and projected to grow at a CAGR of 21% to $322 billion 20341
Justera Signs LOI to Acquire Crypto Company Babbage Mining Co.
TORONTO, ON / ACCESS Newswire / January 29, 2025 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera" or the "Company") is pleased to announce that it has signed a non-binding LOI to acquire 100% of Babbage Mining Co. ("Babbage Mining"), on January 28, 2025 (the "Transaction").
Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025
CAMBRIDGE, MA / ACCESS Newswire / January 29, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 14, 2025 to report its fourth quarter and full year 2024 financial results, and provide a corporate update.
Integrative Providers Association (IPA) and Compassion Center Call on U.S. Senate to Fast Track Robert F. Kennedy Jr.’s Confirmation
Integrative Providers Association, a 501(c)(6) Professional Membership Organization Speaking on Behalf of Over 14 Million Integrative Healthcare Practitioners, and the Compassion Center, Proudly Champions "Secretary Kennedy" as a Maverick in Holistic Health and Nutrition, Urging Our U.S. Senators to Expedite Confirmation In The Name of Wellness. IPA Members Support Robert F. Kennedy's Agenda to Redirect Healthcare In The United States
NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025
SHELTON, CT / ACCESS Newswire / January 29, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it is presenting today, January 29, at 11am at the MicroCap Conference 2025 in Atlantic City, NJ.
Pharmacy CrossRoads Expands: Meet the 4 New Podcast Hosts Shaping the Future of Independent Community Pharmacy
Pharmacy Podcast Network adding additional insights from proven community pharmacy leaders.
Compassion Center, Coalition for Patients' Rights, and Integrative Providers Association Urge Senate to Confirm RFK Jr. as Secretary of Health and Human Services
UNITED SUPPORT FOR RFK JR. AT HHS: The Compassion Center, Coalition for Patients' Rights, and Integrative Providers Association urge the Senate to confirm Robert F. Kennedy Jr. as Secretary of Health and Human Services. Citing his decades-long advocacy for patient rights, environmental responsibility, and integrative care, they see a transformative opportunity to restore trust, champion preventative solutions, and reduce chronic disease. They call for swift action to usher in an era of holistic, compassion-driven leadership. We stand ready.
Angle PLC Announces Analysis of CTC-DNA and ctDNA using Illumina assay
NEW RESULTS FOR dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platformFindings in lung cancer show that CTCs can provide additional biomarkers not found in ctDNA from single blood sampleANGLE invited to present data at EACR-Illumina webinar on 6 February 2025
'No way out': Grim conditions in El Salvador's mega-prison for gangs
Confined to their cells for all but 30 minutes a day, denied visits, forced to sleep on stainless steel cots without mattresses: this is life in Latin America's biggest prison.
Hundreds of millions in Asia celebrate Year of the Snake
Hundreds of millions of people across Asia celebrate the Lunar New Year with their families on Wednesday, as they bid farewell to the Year of the Dragon and usher in the Year of the Snake.
Helicopter crash that killed Leicester City owner ruled an accident
The helicopter crash that killed the owner of Premier League football club Leicester City was an accident, an inquest jury ruled on Tuesday.
Nepal resumes rescue helicopter flights to Mount Everest
Nepali airlines have resumed rescue helicopter flights to the Everest region, an aviation industry official announced Tuesday, following weeks of suspension prompted by protests from locals citing environmental impact and loss of income from trekkers.
Fast-moving fires torch national parks in southeast Australia
Firefighters were desperately trying to stop a cluster of fast-moving blazes in southeast Australia on Tuesday, as thousands of acres of national park burned and a farming community was forced to evacuate.
Dermata Expands Patent Portfolio with Issuance of New U.S. Patent for Next-Generation Acne Treatment
- This is Dermata's first issued U.S. patent for XYNGARI™, which uses its Spongilla technology to topically treat acne -- Dermata expects to announce topline results from its STAR-1 Phase 3 XYNGARI™ clinical trial in March 2025 -- Over 30 million acne patients seek treatment in the U.S. each year, with topical products being first-line therapy -
Creator Economy Spotlighted at the 2025 NAB Show Featuring Headliner Dhar Mann, Top Digital Scripted Content Creator
Expanded Creator Lab to include more tools and content for the creator economy.
SkinCeuticals Announces Opening of SkinCeuticals SkinLab Honolulu in Ala Moana Center
SkinCeuticals Provides State-of-the-Art Skincare to Consumers in the Largest Open Air Shopping Center in the World
Leading Fashion Wholesale Events MAGIC, PROJECT and SOURCING at MAGIC, Return to Las Vegas for the Upcoming Market Season
Bringing together the men's, women's and sourcing fashion communities together, Las Vegas continues to be the destination for brands, buyers and attendees to collaborate and spark innovations
Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow
CHICAGO, IL / ACCESS Newswire / January 28, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that, on January 27, 2025, its wholly owned subsidiary, CosmoFarm S.A. (the "Issuer" or "CosmoFarm"), entered into an agreement with a European bank to issue a €2,200,000 (approximately $2,293,830) secured bond (the "Loan").
More than 50 Years of World of Concrete Drives Global Innovation to Empower the Workforce
The world's largest concrete construction and masonry tradeshow encompasses the future of building through leadership and education, integrating technology, solutions and partnerships.